LAUDA DR. R. WOBSER GMBH & CO. KG
Ergebnis der Suchanfrage nach Häuser
Newsrooms
Inhalte
- Kategorie:
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
- 4mehr
Healthcare Holding Switzerland Acquires Aestheticbedarf
Baar, Switzerland (ots/PRNewswire) - Healthcare Holding Schweiz AG, a leading provider of services and distributor of medical technology in Switzerland, has expanded its portfolio with the acquisition of Aestheticbedarf AG. Healthcare Holding Schweiz is managed by Winterberg Advisory GmbH. Healthcare Holding Schweiz AG has successfully closed the acquisition of Aestheticbedarf AG, headquartered in Affoltern, an ...
mehrThe 2025 HÄUSER-AWARD: simply good houses / The search is on for individual detached houses that are suitable for everyday life
mehrLamia Messari-Becker is named “Thought Leader 2024“
mehr- 2
Hellmann takes over contract logistics for Endress+Hauser in North America
mehr - 4
KUBIKx and Ninepointfive invest 3 Million Euros in new communications service for dispatchers
mehr
- 2
Die Hyperloop Bremse „Bellow rail brake“ gewinnt die 3D Pioneers Challenge 2022
Ein Dokumentmehr Spectrum. The most dangerous artwork
The World's Most Dangerous Artwork / Cancer charity Deutsche Krebshilfe (German Cancer Aid), ADP, and the artistic duo LOW BROS welcomed guests to a somewhat unusual gallery opening
mehrNTT DATA Business Solutions AG
Partner itelligence AG links Production Machines with Business Management / itelligence takes part in the Initiative "Open Industry 4.0 Alliance" (FOTO)
mehrDeutsche Energie-Agentur GmbH (dena)
Energy Efficiency Award 2012 honours pioneering industrial companies / German Energy Agency awards international prize to three innovative projects
Berlin (ots) - To honour exemplary energy-efficiency projects in industry and production, Deutsche Energie-Agentur (dena) - the German Energy Agency - has awarded the Energy Efficiency Award 2012 to three pioneering companies. The first prize goes to HARTING, a manufacturer of connection technology, who is ...
mehrBoehringer Ingelheim Receives Positive Recommendation From European Scientific Committee for a New Once Daily Mirapexin(R) (Pramipexole) Formulation for the Treatment Of Parkinson's Disease
Ingelheim, Germany (ots/PRNewswire) - - For non-U.S. Healthcare Media Boehringer Ingelheim announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending the approval of a once daily formulation for Mirapexin(R) / ...
mehrNew Study Results Support Once Daily, Prolonged Release Formulation of Mirapexin(R)/Sifrol(R) (Pramipexole) for the Treatment of Parkinson's Disease
Ingelheim, Germany (ots/PRNewswire) - - Data for the Once Daily Mirapexin(R)/Sifrol(R) (Pramipexole) Formulation Under Development Show Efficacy, Safety and Tolerability Outcomes Comparable to the Current Immediate Release Formulation for the Treatment of Parkinson's Disease For non-US Healthcare Media First data ...
mehr